Evidence map›Paper›PMID 40588582›Full record

ArticleMolecular diversity2026

JAK3 identified as a key toxicological target of aristolochic acid in clear cell renal cell carcinoma.

Jianhang You, Jianmin You, Yuyu Chen, Ronghui Chen, Zhong Lu, Tao Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianhang You *School of Clinical Medicine, Shandong Second Medical University, Weifang, 261053, China.
Jianmin You *Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Yuyu ChenSchool of Clinical Medicine, Shandong Second Medical University, Weifang, 261053, China.
Ronghui ChenClinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, 350000, China.
Zhong LuSchool of Clinical Medicine, Shandong Second Medical University, Weifang, 261053, China. luzhong@sdsmu.edu.cn.
Tao ZhaoDepartment of Central Laboratory, Shandong Provincial Key Medical and Health Laboratory of Perioperative Precise Anesthesia and Organ Protection Mechanism Research, Rizhao Key Laboratory of Basic Research On Anesthesia and Respiratory Intensive Care, The People's Hospital of Rizhao, Rizhao, 276826, Shandong, China. zttlwj@126.com.

Funding

Taishan Scholar Foundation of Shandong Province tsqn202211380the China Postdoctoral Science Foundation 2023M741864the Medical and Health Technology Project of Shandong Province 202318001632
6 · The paper itself

Abstract

Aristolochic acid (AA) is a naturally occurring toxin widely present in traditional herbal medicines and is well known for its nephrotoxic and carcinogenic effects. Its association with clear cell renal cell carcinoma (ccRCC) has attracted increasing attention, yet the key molecular targets and underlying mechanisms of AA-induced carcinogenesis remain poorly understood. In this study, 62 intersection genes related to both AA exposure and ccRCC were identified by integrating toxicogenomic databases with ccRCC-associated gene profiles. Transcriptomic analysis and weighted gene co-expression network analysis further narrowed this list to six critical candidates. Diagnostic models built using 13 machine learning algorithms demonstrated robust and consistent performance across multiple datasets. Immune infiltration and functional enrichment analyses suggested that several of these genes may contribute to immune remodeling and metabolic dysregulation. Among them, JAK3 stood out due to its significant upregulation, negative correlation with immunosuppressive cell subsets, and strong association with poor prognosis. Although JAK3 exhibited strong binding affinity to AA in docking analysis, molecular dynamics simulations revealed reduced conformational stability and increased flexibility in its kinase domain, suggesting ligand-induced structural perturbation and potential toxic interference. Collectively, these findings identify JAK3 as a critical toxicological target of AA in ccRCC and demonstrate the power of toxicogenomic and multi-omics integration in uncovering environment-related carcinogenic mechanisms.

Indexed as

Aristolochic AcidsCarcinoma, Renal CellJanus Kinase 3Kidney NeoplasmsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMolecular Docking SimulationMolecular Dynamics Simulationaristolochic acid IAristolochic AcidsJAK3 protein, humanJanus Kinase 3Aristolochic acidClear cell renal cell carcinomaImmune microenvironmentMachine learningMolecular dockingNetwork toxicologyWGCNA analysis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.